SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
SC 13G/A	An amendment to the SC 13G filing	Dec 14, 2023	View HTML 0000929638-23-003426.pdf 0000929638-23-003426.rtf 0000929638-23-003426.xls
4	Statement of changes in beneficial ownership of securities	Dec 12, 2023	View HTML 0000929638-23-003419.pdf 0000929638-23-003419.rtf 0000929638-23-003419.xls
4/A	Amendment to a previously filed 4	Dec 11, 2023	View HTML 0001562180-23-008273.pdf 0001562180-23-008273.rtf 0001562180-23-008273.xls
8-K	Report of unscheduled material events or corporate event	Dec 08, 2023	View HTML 0001193125-23-290820.pdf 0001193125-23-290820.rtf 0001193125-23-290820.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
8-K	Report of unscheduled material events or corporate event	Dec 08, 2023	View HTML 0001193125-23-291662.pdf 0001193125-23-291662.rtf 0001193125-23-291662.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
SC 13D/A	An amendment to a SC 13D filing	Dec 08, 2023	View HTML 0001193125-23-291815.pdf 0001193125-23-291815.rtf 0001193125-23-291815.xls
424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	Dec 07, 2023	View HTML 0001193125-23-290270.pdf 0001193125-23-290270.rtf 0001193125-23-290270.xls
4	Statement of changes in beneficial ownership of securities	Dec 07, 2023	View HTML 0001562180-23-008222.pdf 0001562180-23-008222.rtf 0001562180-23-008222.xls
4	Statement of changes in beneficial ownership of securities	Dec 07, 2023	View HTML 0001840315-23-000007.pdf 0001840315-23-000007.rtf 0001840315-23-000007.xls
4	Statement of changes in beneficial ownership of securities	Dec 06, 2023	View HTML 0000929638-23-003383.pdf 0000929638-23-003383.rtf 0000929638-23-003383.xls

Data provided by Kaleidoscope.